Начало・Списък с акции・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Отворен

СекторЗдравеопазване

79.09 -0.63

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

77.72

Максимум

80.16

Ключови измерители
By Trading Economics
Приходи	-61K 27M
Продажби	-9.6M 237M
P/E Средно за сектора	20.044 64.641
EPS	1.68
Марж на печалбата	11.551
Служители	970
EBITDA	-20M 57M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+36.15% upside

Дивиденти
By Acuity
Следващи печалби	7.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-91M 1.8B
Предишно отваряне	79.72
Предишно затваряне	79.09

Настроения в новините

By Acuity

14%

86%

19 / 340 Класиране в Healthcare

ANI Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 19:46 ч. UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31.07.2026 г., 20:06 ч. UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30.07.2026 г., 20:09 ч. UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29.07.2026 г., 19:19 ч. UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28.07.2026 г., 20:02 ч. UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24.07.2026 г., 20:06 ч. UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22.07.2026 г., 20:01 ч. UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21.07.2026 г., 20:12 ч. UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20.07.2026 г., 19:46 ч. UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Сравнение с други в отрасъла

Ценова промяна

ANI Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

36.15% нагоре

12-месечна прогноза

Среден 109 USD 36.15%

Висок 124 USD

Нисък 91 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за ANI Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на ANI Pharmaceuticals Inc през последните 3 месеца.

Настроение

By Acuity

19 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.